Ellen van der Aar

Ellen van der Aar received her M.Sc. degree in chemistry from the Free University in Amsterdam (The Netherlands) and a Ph.D. degree in Molecular Toxicology from the same university in 1997. After different assignments focused on DMPK and toxicology at several pharma and biotech companies, she joined Galapagos NV in Mechelen (Belgium) in 2008. Initially she headed the DMPK/safety department in Research, and subsequently moved to a role as Development Project Leader in 2013. In this role, she brings preclinical candidates to first-in-human and Phase 2 proof-of-concept studies, together with a team of functional experts.